Open Orphan sets sights on €100m valuation

Open Orphan sets sights on €100m valuation

Open Orphan is targeting a valuation of €100 million in the next year after it completes the reverse takeover of drug services company Venn Life Sciences.

Open Orphan is currently in the middle of a fundraising round with the company seeking a modest amount of new cash, understood to be less than €10 million, from investors, according to market sources. The company and its advisers, IBI Corporate Finance, met with potential new investors in London last...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post